Xpreza 200 mg Tablet is classified as an anti-cancer medication known as a demethylation agent, and it is prescribed for the ongoing treatment of acute myeloid leukaemia in adults who have shown improvement after chemotherapy but were unable to complete intensive curative therapy.
Acute myeloid leukaemia is a cancer that originates in the blood-forming cells of the bone marrow.
The active ingredient in Xpreza 200 mg Tablet is Azacitidine, which functions by disrupting the growth of cancer cells, leading to their eventual destruction by the body. It supports the bone marrow in producing normal blood cells while eliminating abnormal cells present in the bone marrow.
Occasionally, Xpreza 200 mg Tablet may lead to side effects such as nausea, vomiting, diarrhea, constipation, fatigue, and abdominal pain. Most of these side effects are typically mild and may not necessitate medical intervention, resolving on their own over time. However, do not hesitate to consult your doctor if any side effects persist or worsen.
Xpreza 200 mg Tablet should not be used if you are pregnant or breastfeeding. If you become pregnant while undergoing treatment with Xpreza 200 mg Tablet, seek medical advice immediately. This medication is not advised for children, as its safety and efficacy have not been established in this age group. Be sure to inform your doctor about your health status and any medications you are taking to avoid potential side effects or interactions.
